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Training caregivers of disabled patients after stroke
At least a third of stroke survivors remain disabled, 
making stroke the third leading cause of disability-
adjusted life-years (DALYs) worldwide.1,2 Most (about 
75%) disabled survivors of stroke need assistance to 
undertake personal, domestic, and community-based 
activities of daily living.3 Assistance is often provided 
informally by family and friends who might be ill-
informed or ill-prepared physically and emotionally.3 
Informal caregiving imposes a persistent burden on 
25–50% of caregivers, dependent on the mental he alth, 
mood, and requirements of the caregiver as well as on 
the age, mental health, and function of the patient.4–7 
Caregiver burden can compromise caregivers’ health 
and patients’ rehabilitation and recovery.4–7
Non-pharmacological interventions to reduce the 
burden on informal caregivers and facilitate patients’ 
recovery after stroke have been assessed in eight 
randomised trials including 1007 participants.8 Of 
these interventions, the most promising one is the 
London Stroke Caregivers Training Course (LSCTC).8,9 
In a randomised trial within a single stroke unit,9 the 
caregivers received the LSCTC while the caree was still 
an inpatient. The LSCTC facilitated earlier hospital 
discharge of the patient and reduced caregivers’ stress, 
strain, and depression.8,9 However, whether the LSCTC 
was eﬃ  cient in other stroke units was unknown.
In The Lancet, Anne Forster and colleagues10 report the 
results of the training caregivers after stroke (TRACS) 
trial of the LSCTC in several stroke units throughout the 
UK. In this cluster randomised trial,10 36 stroke units were 
randomly assigned to either the LSCTC group (n=18, 
containing 450 dyads of patients and caregivers) or 
usual care (n=18, containing 478 dyads). The LSCTC was 
incorporated into routine practice by the multidisciplinary 
team of every assigned stroke unit, and carers were given 
(1) individualised information about stroke and instruc-
tions about communication, nutrition, positioning, gait 
facilitation, continence, secondary prevention, medicine 
compliance, and anticipation and prevention of stroke-
related complications (eg, pressure areas); (2) advice on 
local services; and (3) hands-on training in assisting with 
personal activities of daily living, lifting and handling 
techniques, and facilitation of mobility and transfers.
At 6 months after randomisation, the caregivers’ 
burden, assessed by the caregiver burden scale in 
673 (73%) of the 928 caregivers, was similar between 
caregivers allocated the LSCTC intervention and those 
allocated usual care (adjusted mean scores: 45·5 for 
the intervention group vs 45·0 for the control group; 
diﬀ erence 0·5 points, 95% CI –1·7 to 2·7).10 Patients’ 
functional outcome, as measured by the self-reported 
Nottingham activities of daily living score in 690 (74%) 
of the 928 patients, was similar between patients 
allocated the LSCTC intervention and those allocated 
usual care (adjusted mean scores 27·4 vs 27·6; diﬀ erence 
–0·2 points, –3·0 to 2·5).10 The mean cost of the LSCTC 
intervention was only £82 per patient, but the total 
patient costs and quality-adjusted life-years (QALYs) for 
patients and caregivers at any assessment were similar 
between the intervention and control groups, and the 
probability that the intervention was cost-eﬀ ective, at 
accepted thresholds of £20 000 to £30 000 per QALY 
gained, was low.10
How do we interpret the discordant positive results of 
the small, single-centre randomised trial including indiv-
iduals9 and the negative results of a larger, multicentre, 
randomised trial including clusters of stroke units?10 
Similar examples of initial positive, and subsequent 
nega tive, results of randomised trials of other medical 
interventions populate the medical literature.11,12 The usual 
explanation is a false positive initial study due to random 
error associated with small numbers of patients.
The initial single-centre randomised trial might 
have been a true positive, and the TRACS result a false 
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negative, if any of the following three circumstances 
prevailed. First, if the outcomes of the 26% of patients 
and 27% of caregivers who failed to complete follow-up 
in TRACS were substantially diﬀ erent to the outcomes of 
those who completed follow-up. Second, if suboptimum 
com pliance with the intervention (average 44%) and 
com pletion of training records (72%) in TRACS minimised 
or negated a real eﬀ ect—intervention compliance did not 
correlate with caregiver or patient outcome, however. 
Finally, if the LSCTC has been incorporated into usual 
care, thus minimising the diﬀ erence between treatment 
groups. This ﬁ nal situation is unlikely since no evidence 
of widespread use of the LSCTC in routine care has been 
noted and the burden of caregiving for disabled stroke 
survivors remains substantial.4,5,7
I believe the TRACS results are a true negative. The 
internal validity of the results are supported by the 
balanced covariates between treatment groups, use 
of appropriate outcome measures, and consistency of 
the primary results with the secondary physical and 
psychological outcomes of patients and caregivers 
at 6 and 12 months. External validity is supported by 
consistent results among 36 stroke units throughout 
four regions of the UK.
The initial single-centre trial might have been a true 
positive and the subsequent TRACS results a true negative 
because the LSCTC may be eﬃ  cacious only when given 
under ideal circumstances by the multidisciplinary team 
who developed it, or by teams with similar expertise, 
enthusiasm, and intensity. When given under usual 
circum stances, in diﬀ erent geographical and health-
care settings and cascaded down by staﬀ  attending the 
training days to other ward workers, as in TRACS, its 
eﬀ ectiveness might have been diluted or even negated.
The implication of TRACS’ results10 for clinicians is that 
inpatient delivery of the LSCTC is not more eﬀ ective or 
cost-eﬀ ective than usual care in reducing the burden 
of caregiving or improving the functional outcome of 
disabled stroke survivors. The implications for researchers 
are that multicentre, cluster randomised trials of stroke 
rehabilitation strategies are feasible, but also challenging 
in adherence, compliance, and follow-up. Future trials 
should assess the potential complementary beneﬁ ts 
of supplementing initial inten sive hospital-based 
train ing of carers with integrated home-based and 
community-based carer training and support over the 
long term. Meanwhile, we await the results of a recently 
completed cluster randomised trial of a system of care for 
800 community-based patients who have had a stroke 
and their carers, in 32 stroke services across the UK, which 
was delivered by health professionals undertaking a 
community-based liaison or coordinating role, and which 
aimed to meet the longer-term needs for stroke survivors 
and their carers living at home.13
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